BR112018071958A2 - composição - Google Patents

composição

Info

Publication number
BR112018071958A2
BR112018071958A2 BR112018071958A BR112018071958A BR112018071958A2 BR 112018071958 A2 BR112018071958 A2 BR 112018071958A2 BR 112018071958 A BR112018071958 A BR 112018071958A BR 112018071958 A BR112018071958 A BR 112018071958A BR 112018071958 A2 BR112018071958 A2 BR 112018071958A2
Authority
BR
Brazil
Prior art keywords
composition
excretory
treatment
bacterial infections
relates
Prior art date
Application number
BR112018071958A
Other languages
English (en)
Inventor
Mercati Valentino
Mattoli Luisa
Maidecchi Anna
Lugli Andrea
Original Assignee
Aboca S.P.A. Società Agricola
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aboca S.P.A. Società Agricola filed Critical Aboca S.P.A. Società Agricola
Publication of BR112018071958A2 publication Critical patent/BR112018071958A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

a presente invenção se refere a uma composição compreendendo extrato de botões de álamo para uso no tratamento da cavidade orofaríngea, aparelho urinário, aparelho digestivo/excretor, afecções da pele e de infecções bacterianas.
BR112018071958A 2016-05-24 2017-05-22 composição BR112018071958A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUA2016A003755A ITUA20163755A1 (it) 2016-05-24 2016-05-24 Composizioni a base di gemme di pioppo e loro usi
PCT/IB2017/053000 WO2017203414A1 (en) 2016-05-24 2017-05-22 Compositions comprising extract of poplar buds and uses thereof

Publications (1)

Publication Number Publication Date
BR112018071958A2 true BR112018071958A2 (pt) 2019-02-05

Family

ID=57045271

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018071958A BR112018071958A2 (pt) 2016-05-24 2017-05-22 composição

Country Status (9)

Country Link
US (1) US11839638B2 (pt)
EP (1) EP3463409A1 (pt)
JP (1) JP7114486B2 (pt)
CN (1) CN109152806A (pt)
AU (1) AU2017271261B2 (pt)
BR (1) BR112018071958A2 (pt)
EA (1) EA201892349A1 (pt)
IT (1) ITUA20163755A1 (pt)
WO (1) WO2017203414A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20163755A1 (it) 2016-05-24 2017-11-24 Aboca Spa Societa Agricola Composizioni a base di gemme di pioppo e loro usi

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2135201C1 (ru) * 1998-01-20 1999-08-27 Куркин Владимир Александрович Способ получения настойки тополя для лечения гнойно-воспалительных заболеваний мягких тканей
JP3091962B2 (ja) 1998-09-25 2000-09-25 アルプス薬品工業株式会社 テストステロン−５α−レダクターゼ阻害剤
FR2793141B1 (fr) * 1999-05-05 2003-08-08 Fabre Pierre Dermo Cosmetique Extrait de bourgeons de peuplier et son association avec le squalane pour son utilisation en tant que medicament anti-inflammatoire et dans un procede de traitement cosmetique
CN1666753A (zh) * 2004-03-12 2005-09-14 北京大学 一种有抗癌活性的杨属植物芽或芽鳞提取物
JP5414776B2 (ja) * 2004-06-17 2014-02-12 森川健康堂株式会社 プロポリス抽出物の粉末状組成物及びその製造方法
GB201001412D0 (en) * 2010-01-28 2010-03-17 Natures Lab Ltd Propolis and process for the treatment thereof
AU2014250139B2 (en) * 2013-04-05 2019-09-12 Manuka Health New Zealand Limited Therapeutic compositions and uses thereof
CN103315191B (zh) * 2013-07-18 2014-09-03 广南(湛江)家丰饲料有限公司 一种猪用免疫增强剂及其制备方法
ITRM20130592A1 (it) * 2013-10-25 2015-04-26 Aboca Spa Societa Agricola Composizione per la tosse.
ITUA20163755A1 (it) 2016-05-24 2017-11-24 Aboca Spa Societa Agricola Composizioni a base di gemme di pioppo e loro usi

Also Published As

Publication number Publication date
AU2017271261A1 (en) 2018-10-25
WO2017203414A1 (en) 2017-11-30
US11839638B2 (en) 2023-12-12
CN109152806A (zh) 2019-01-04
EP3463409A1 (en) 2019-04-10
JP2019516740A (ja) 2019-06-20
AU2017271261B2 (en) 2020-04-09
EA201892349A1 (ru) 2019-04-30
US20200101127A1 (en) 2020-04-02
JP7114486B2 (ja) 2022-08-08
ITUA20163755A1 (it) 2017-11-24

Similar Documents

Publication Publication Date Title
PH12016500866A1 (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
CO6680687A2 (es) Inmunoglobinas con dominio variable dual capaces de unirse a il 1 beta e il-17, composiciones farmaceúticas y conjugados de proteína de unión de las mismas
BR112017011923A2 (pt) bactéria modificada para tratar doenças associadas com hiperamonemia
CO6690781A2 (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
DOP2012000122A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
DOP2012000104A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
BR112013031794A2 (pt) novos derivados de oxintomodulina e composição farmacêutica para o tratamento da obesidade compreendendo os mesmos
WO2019066577A3 (ko) 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물
BR112018069023A2 (pt) métodos de tratamento de doenças colestáticas
BR112015027536A8 (pt) composição compreendendo bactérias ácidas lácticas para utilização no tratamento preventivo e/ou curativo de cistite recorrente.
AR079160A1 (es) Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
EP3458454A4 (en) NEW MITOCHONDRIAL DECOUPLANTS FOR THE TREATMENT OF METABOLIC DISEASES AND CANCER
MX2017009417A (es) Formas solidas de acido 2-(5-(3-fluorofenil)-3-hidroxipicolinamido )acetico, composiciones y usos de las mismas.
CR20120508A (es) PROTEÍNA DE FUSIÓN ROBO1-Fc Y SU UTILIZACIÓN EN EL TRATAMIENTO DE TUMORES
EP3810124A4 (en) COMPOSITION FOR THE TREATMENT OF DRY EYE AND MEIBOMIANITIS
EP3678640A4 (en) METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY SKIN DISEASE
EP3582768A4 (en) CANNABINOID FORMULATIONS FOR THE TREATMENT OF DERMATITIS AND INFLAMMATORY SKIN DISEASES
EP3452578A4 (en) METHOD FOR IN VITRO PRODUCTION OF MAGNETIC FUNDAMENTAL FABRICS AND COMPOSITIONS RELATED THEREWITH
IL266619A (en) Treatment of diseases and infections of the respiratory tract with ascorbic acid preparations
AU2017260532A1 (en) Methods and devices for preparation of ultrasound contrast agents
EP3843765A4 (en) THERAPEUTIC COMBINATIONS OF BOSWELLIA EXTRACT AND CANNABINOIDS
EP3615121A4 (en) TRANSNASAL CATHETER FOR IMAGING AND BIOPSIZING INTERNAL LUMINAL ORGANS
BR112018071958A2 (pt) composição
EP3509614A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF LAFORA DISEASE

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2671 DE 15-03-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.